Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Research Council grant · Running

DaVinci-Switches Designing Allosteric Protein Switches by In Vivo Directed Evolution and Computational Inference

Coordinator
Ruprecht-Karls-Universitaet Heidelberg, Germany
Runs
1 September 2022 to 31 August 2027
Status
Running
EU funding
€1.6m
Total cost
€1.6m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101041570

What the project is doing

In the project's own words, from its summary on CORDIS.

Proteins are molecular machines that drive all major functions in cells. Controlling the activity of proteins in real time via light or chemicals is a central goal in synthetic biology. The design of switchable proteins, in particular single-chain, allosteric variants, however, is a challenging engineering problem thus-far mostly addressed by trial-and-error. DaVinci-Switches takes a radically new, data-driven perspective to fundamentally advance our understanding of protein allostery and accelerate and eventually rationalize the engineering of switchable proteins by interfacing synthetic biology with machine learning.

We will establish a 'design by directed evolution' approach to create switchable proteins through receptor and effector fusion followed by phage-assisted in vivo directed evolution using synthetic gene circuits for selection. We will apply this novel pipeline to a diverse set of effector proteins and monitor the evolutionary process by next-generation sequencing (Objective 1). In parallel, we will perform an in-depth computational analysis of domain insertions within the natural protein repertoire.

The combined, rich datasets will be used to train machine learning models to infer sequence patterns predictive of domain insertion tolerance and allosteric coupling between receptor-effector pairs (Objective 2). Finally, we will employ this unique model to design light- and drug-inducible variants of the Yamanaka cell reprogramming factors. These will provide the foundation of an Adeno-associated virus-based platform for cyclic, partial in vivo reprogramming of somatic cells with enormous potential for regenerative medicine, which will be evaluated in a murine model of drug-induced liver injury (Objective 3).

DaVinci-Switches harnesses our key competences in protein engineering, synthetic biology and computation to reveal fundamental principles of allostery and enable transformative advances in the design of switchable proteins for research and medicine.

Topics

Who is involved

OrganisationCityCountryRole
Ruprecht-Karls-Universitaet HeidelbergHeidelbergGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI